Imlifidase: First Approval
This article summarizes the milestones in the development of imlifidase leading to this first approval for desensitization treatment of highly sensitized adult kidney transplant patients with positive crossmatch against an available deceased d onor.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research